A novel tumor-specific gene therapy for bladder cancer
- 1 August 1999
- journal article
- Published by Elsevier in Medical Hypotheses
- Vol. 53 (2) , 130-135
- https://doi.org/10.1054/mehy.1998.0731
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997
- The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year OutcomeJournal of Urology, 1997
- Clinical implications of telomerase in cancerEuropean Journal Of Cancer, 1997
- A Mammalian Telomerase-Associated ProteinScience, 1997
- Detection of Minimal Residual Disease in Hematopoietic TissuesAnnals of the New York Academy of Sciences, 1995
- p16 (CDKN2) is a major deletion target at 9p21 in bladder cancerHuman Molecular Genetics, 1995
- The dominating effect of mutant p53Nature Genetics, 1995
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- Bacteriophage P1 cre gene and its regulatory regionJournal of Molecular Biology, 1986